New drug trial targets advanced MASH liver damage
NCT ID NCT06903065
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 30 times
Summary
This early-stage study tests a new medicine called RO7790121 in 50 adults with advanced liver scarring (fibrosis) caused by MASH. The main goal is to check the drug's safety and how the body processes it. Participants must have a certain body mass index and liver stiffness level. The study does not aim to cure the disease but to gather information for future treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MASH are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Adobe Clinical Research, LLC
Tucson, Arizona, 85712, United States
-
Bellaire Clinical Research, LLC
Bellaire, Texas, 77401, United States
-
Centro de Investigacion y Gastroenterologia
Mexico City, Mexico CITY (federal District), 06700, Mexico
-
DHR Health Institute for Research and Development
Edinburg, Texas, 78539, United States
-
Delta Research Partners, LLC (Bastrop)
Bastrop, Louisiana, 71220, United States
-
FDI Clinicial Research - Mayaguez
Mayagez, 00680, Puerto Rico
-
Fundacion Santos Y De La Garza Evia IBP
San Pedro Garza García, Nuevo León, 66278, Mexico
-
Fundacion de Investigacion de Diego
San Juan, 00927, Puerto Rico
-
GI Alliance
Southlake, Texas, 76092, United States
-
Gastrointestinal Specialists of Georgia, PC
Marietta, Georgia, 30060, United States
-
Innovative Clinical Research
Clarksville, Tennessee, 37040, United States
-
Jubilee Clinical Research NV, LLC
Las Vegas, Nevada, 89106, United States
-
Pinnacle Clinical Research - Austin
Austin, Texas, 78757, United States
-
Pinnacle Clinical Research Georgetown
Georgetown, Texas, 78626, United States
-
Pinnacle Clinical Research, PLLC
San Antonio, Texas, 78229, United States
Conditions
Explore the condition pages connected to this study.